Clinical Trials Logo

Filter by:
  • Not yet recruiting  
  • « Prev · Page [3]
NCT ID: NCT00406861 Not yet recruiting - Leprosy Clinical Trials

Montelukast in ENL Reaction

Start date: December 2006
Phase: N/A
Study type: Interventional

Objective of the trial is to assess the safety and efficacy of Montelukast in treatment of Erythema Nodosum leprosum (ENL) reaction in multibacillary leprosy patients either in combination with prednisolone or alone. Hypothesis is that montelukast will reduce the severity of ENL reaction in Multibacillary leprosy patients without causing an unacceptably high incidence of adverse effects. Design is a multicentre hospital-based single-blind prospective trial for leprosy patients with ENL reaction. prior written consent will be taken from the patients who will undergo the trial. Endpoints are decrease in severity of ENL and absence of new nerve function impairment